EFDID: 511567EFD: View Filing

Issuer: CoRegen, Inc. (0002012886) - D

Accession: 0002012886-24-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    CoRegen, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2022)
  • Address:
    600 E HOPKINS AVE
    STE 304

    ASPEN, CO 81611
  • Persons:
    Related Persons 7
    John C. Thomas, Jr.
    Executive Officer 
    Chief Financial Officer of the Issuer
    David Lonard, PhD
    Executive Officer 
    Chief Science Officer of the Issuer
    Steve Gorlin
    Executive Officer, Director 
    Chief Executive Officer of the Issuer
    Bert W. O'Malley, M.D.
    Director
    Clifford C. Dasco, M.D.
    Director
    Edward J. Benz, Jr.
    Director
    David M. Cornell, II
    Director
EDGAR: Offering Information
  • Accession Date:
    02/21/2024
  • First Sale Date:
    02/08/2024
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $14,500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

Notices found in EFD

Filed:TX
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
CoRegen, Inc./s/ John C. Thomas, Jr.John C. Thomas, Jr.Chief Financial Officer2024-02-21